Stock detail
Alnylam Pharmaceuticals, Inc. (ALNY) stock price, chart, and key data
View Alnylam Pharmaceuticals, Inc. stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alnylam Pharmaceuticals, Inc.
ALNY · XNAS
-$13.81 (-4.43%) past month
$297.70
After hours $298.53 (+0.28%)
Key metrics
Close price
$297.70
52-week range
$284.19 - $495.55
Market cap
$40.1B
About the company
Alnylam Pharmaceuticals, Inc
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app